Anixa Biosciences is trading 6.03% up now at $3.69 in after-hours trading after closing at $3.48 on August 28, 2026, with no confirmed company-specific catalyst.

  • No company-specific announcement dated August 28 explains the move; latest listed releases concern conference presentations and earlier clinical or patent updates.
  • Broader market conditions were mixed, while after-hours activity remained relatively light.
  • The catalyst is therefore unconfirmed and may reflect speculative trading.